Skip to main contentSkip to navigation
Ovarian Cancer Research Alliance
Research Exchange
Donate

Investigator

Mina Sakata

Osaka International Cancer Institute

Research Interests

MSMina Sakata
Papers(1)
Extraovarian seromuci…
Institutions(1)
Osaka International C…

Papers

Extraovarian seromucinous borderline tumor: Case report and literature review

Abstract Seromucinous borderline tumors (SMBT) are papillary neoplasms without invasive capabilities. Originally categorized as ovarian tumors, SMBT, being an endometriosis‐related tumor, can manifest beyond the ovaries. To date, only four cases of extraovarian SMBT have been documented in literature. In this report, we present our experience with the first case of SMBT in the uterine cervix, which exhibited highly elevated CA19‐9 levels. The patient, initially clinically diagnosed with cervical cancer, underwent treatment with radical hysterectomy and was later pathologically diagnosed with SMBT of the uterine cervix. While extraovarian SMBT, especially in the uterine cervix, is extremely rare, this condition should be considered in patients with cervical masses lacking pathological evidence of malignant disease but displaying elevated CA19‐9 levels.

1Works
1Papers
Uterine Cervical Neoplasms
Links & IDs
0009-0008-6026-7811
Ovarian Cancer Research Alliance

A global leader in the fight against gynecologic cancer

LIVING LAB
Join the Living LabOur TeamGovernance & EthicsShareable Resources
DISCOVERY LAB
Discovery LabHow It WorksUpcoming WebinarsContribute Data
ABOUT
About OCRAGet InvolvedMake a DonationContact Us

© 2025 Ovarian Cancer Research Alliance, Inc.

PrivacyTermsAccessibility